250 related articles for article (PubMed ID: 34192412)
1. Topical calcineurin inhibitors as a double-edged sword in rosacea: A systematic review.
Zhang H; Yang L; Wang Y; Zhang D; Tang K; Fang R; Sun Q
J Cosmet Dermatol; 2022 Apr; 21(4):1695-1704. PubMed ID: 34192412
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
3. Rosacea-like eruption due to topical pimecrolimus.
El-Heis S; Buckley DA
Dermatol Online J; 2015 May; 21(5):. PubMed ID: 26295863
[TBL] [Abstract][Full Text] [Related]
4. Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis.
Sun SL; Liu JJ; Zhong B; Wang JK; Jin X; Xu H; Yin FY; Liu TN; Chen QM; Zeng X
Br J Dermatol; 2019 Dec; 181(6):1166-1176. PubMed ID: 30903622
[TBL] [Abstract][Full Text] [Related]
5. Pimecrolimus for treatment of acne rosacea.
Crawford KM; Russ B; Bostrom P
Skinmed; 2005; 4(3):147-50. PubMed ID: 15891250
[TBL] [Abstract][Full Text] [Related]
6. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
[TBL] [Abstract][Full Text] [Related]
7. Off-label Uses of Topical Pimecrolimus.
Ladda M; Sandhu V; Ighani A; Yeung J
J Cutan Med Surg; 2019; 23(4):442-448. PubMed ID: 31053034
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical calcineurin inhibitors in psoriasis.
Wang C; Lin A
J Cutan Med Surg; 2014; 18(1):8-14. PubMed ID: 24377467
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of topical calcineurin inhibitors in lichen planus.
Samycia M; Lin AN
J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
[TBL] [Abstract][Full Text] [Related]
10. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
11. Pimecrolimus 1% cream for the treatment of rosacea.
Kim MB; Kim GW; Park HJ; Kim HS; Chin HW; Kim SH; Kim BS; Ko HC
J Dermatol; 2011 Dec; 38(12):1135-9. PubMed ID: 21954922
[TBL] [Abstract][Full Text] [Related]
12. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
Karabulut AA; Izol Serel B; Eksioglu HM
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
[TBL] [Abstract][Full Text] [Related]
13. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis.
Fröschl B; Arts D; Leopold C
GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
17. Ethanol-induced flushing with topical pimecrolimus use.
Ogunleye T; James WD
Dermatitis; 2008; 19(2):E1-2. PubMed ID: 18413100
[TBL] [Abstract][Full Text] [Related]
18. Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence.
Iskedjian M; Piwko C; Shear NH; Langley RG; Einarson TR
Am J Clin Dermatol; 2004; 5(4):267-79. PubMed ID: 15301573
[TBL] [Abstract][Full Text] [Related]
19. [Steroid-aggravated rosacea: successful therapy with pimecrolimus].
Meykadeh N; Meiss F; Marsch WC; Fischer M
Hautarzt; 2007 Apr; 58(4):338-42. PubMed ID: 16874534
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]